CORMEDIX INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.25 USD | -1.50% |
|
-7.98% | +39.63% |
| 05-09 | Transcript : CorMedix Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 05-09 | CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 289M | - | - | - | - | - | |
| 78.37B | ||||||
| 9.08B | ||||||
| 5.06B | ||||||
| 4.85B | - | - | ||||
| 2.37B |
- Stock Market
- Equities
- CRMD Stock
- Charts CorMedix Inc.
- Sector Chart
